Healthy people and a Healthy planet
That is what FeyeCon aims for. Using CO₂ based processes for drug isolation, purification and formulation we create completely new and improved pharmaceutical and biomedical products. Our CO₂ technology is mild and leaves no residual solvents. It offers a very versatile and tunable process.
Our mild and versatile CO₂ technology achieves:
- High drug bioavailability
- Increased product shelf-life
- Improved patient wellbeing
- Straightforward GMP upscaling
Our particles are characterized by:
- High bioavailability
- Tunable particle properties: size, morphology, density, crystal structures, polymorphisms
- Tunable drug release properties
- Full structural preservation of sensitive drugs
- Different routes of administration
GMP Clean Room Facility
At our laboratory in Weesp, The Netherlands, we have cGMP facilities that operate supercritical CO₂ equipment available to external parties. Our facilities - including a certified class D cleanroom - allow for the cGMP production of clinical batches and contract manufacturing.